- Home
- MIST vs NTRB Comparison
MIST vs NTRB Comparison
Compare MIST & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- NTRB
- Stock Information
- Founded
- MIST 2003
- NTRB 2016
- Country
- MIST Canada
- NTRB United States
- Employees
- MIST N/A
- NTRB N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- MIST Health Care
- NTRB Health Care
- Exchange
- MIST Nasdaq
- NTRB Nasdaq
- Market Cap
- MIST 81.5M
- NTRB 77.9M
- IPO Year
- MIST N/A
- NTRB N/A
- Fundamental
- Price
- MIST $1.43
- NTRB $6.17
- Analyst Decision
- MIST Strong Buy
- NTRB
- Analyst Count
- MIST 3
- NTRB 0
- Target Price
- MIST $13.00
- NTRB N/A
- AVG Volume (30 Days)
- MIST 177.8K
- NTRB 28.2K
- Earning Date
- MIST 11-11-2024
- NTRB 12-11-2024
- Dividend Yield
- MIST N/A
- NTRB N/A
- EPS Growth
- MIST N/A
- NTRB N/A
- EPS
- MIST N/A
- NTRB N/A
- Revenue
- MIST N/A
- NTRB $1,803,816.00
- Revenue This Year
- MIST N/A
- NTRB N/A
- Revenue Next Year
- MIST N/A
- NTRB N/A
- P/E Ratio
- MIST N/A
- NTRB N/A
- Revenue Growth
- MIST N/A
- NTRB N/A
- 52 Week Low
- MIST $1.12
- NTRB $1.93
- 52 Week High
- MIST $3.52
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- MIST 42.50
- NTRB 50.57
- Support Level
- MIST $1.41
- NTRB $5.24
- Resistance Level
- MIST $1.53
- NTRB $6.40
- Average True Range (ATR)
- MIST 0.07
- NTRB 0.71
- MACD
- MIST -0.01
- NTRB -0.12
- Stochastic Oscillator
- MIST 26.96
- NTRB 33.23
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.